Tandem Diabetes Care Reports First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- US stock index futures slip as high-stakes Iran, inflation tests loom
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
Tandem Diabetes Care (TNDM) PT Raised to $7.50 at Stifel
April 27, 2018 10:32 AM EDTStifel raised its price target on Tandem Diabetes Care (NASDAQ: TNDM) to $7.50 while maintaining a Hold rating.
... MoreTandem Diabetes Care (TNDM) PT Raised to $9 at Cowen; More Upside
April 27, 2018 7:48 AM EDTCowen raised its price target on Tandem Diabetes Care (NASDAQ: TNDM) to $9.00 (from $7.00) while maintaining a Outperform rating.
Analyst Doug Schenkel commented, "TNDM posted a solid Q1 beat. We expect numerous revenue growth catalysts (new products, renewals, Animas, international, infusion sets) to drive upside to... More
